ANATOMY OF THE SHORT TERM $GENZ (GENZYME) TRADE

Stock price of Genzyme spiked on the news that  FDA granted approval to  Lumizymethel (aglucosidase alfa) for the treatment of late onset Pompe disease. Pompe disease is a rare  and often fatal condition that disables the heart and muscles due to deficiency of ...
Read more »

EXITING $GENZ WITH PROFIT AT $49.30

www.thearorareport.com THE ARORA REPORT, Ltd. HOME OF THE UNIQUE ZYX CHANGE METHOD DEDICATED SOLELY TO PROFIT FROM CHANGE BY TRADING AND INVESTING VERIFIABLE PERFORMANCE RECORD Every closed trade since 2007, without exception, is included in the performance results. Number of ...
Read more »
Follow

Get every new post delivered to your Inbox

Join other followers